capsaicin
Drug data last refreshed 2d ago
QUTENZA is a topical capsaicin patch indicated for the treatment of neuropathic pain, particularly postherpetic neuralgia (PHN). Applied as a transdermal patch, capsaicin works by depleting substance P, a neuropeptide involved in pain transmission, providing localized pain relief at the application site. The product represents a non-systemic approach to managing chronic neuropathic pain conditions where oral analgesics may be ineffective or poorly tolerated.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Alcohol Neurolysis and Capsaicin for Postamputation Pain (PAP)
Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model
Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)
Capsaicin for Cerebral Perfusion Augmentation.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moLOE in ~4 years — strategic planning for patent cliff underway
QUTENZA's specialized indication and mature lifecycle stage create opportunities for regional sales representatives, formulary specialists, and medical science liaisons focused on pain management and neurology. Success requires deep knowledge of neuropathic pain pathophysiology, payer reimbursement strategies, and healthcare provider relationships within specialty pain clinics and dermatology. Currently, zero open positions are linked to this product, reflecting its mature, stable market status with limited expansion activities.